- News & Features
CreakyJoints was born at 3 a.m. one morning in 1999.
An association between obesity and psoriatic arthritis has been established.
Boehringer Ingelheim announced it had enrolled the first patient in a study intended to demonstrate that a biosimilar is interchangeable with Humira (adalimumab) for treating patients with moderate-to-severe chronic plaque psoriasis.
Fibromyalgia, a disorder that affects and amplifies the ways the brain feels pain, can “mask” underlying spondyloarthritis.
Even if each new study is correct, “it may only be one star in the sky.”
Do you fit the description? Katie Golden from Goldengraine.com shares with us the many roles disabled chronic disease patients need to fill.
We are proud to announce we’ve hit an important milestone: The ArthritisPower community has donated over 50,000 patient reported outcomes to research!
In tests, seven out of 10 patients who took the newly-approved drug experienced improvements in their skin of at least 90 percent, and 80 percent saw cleared or almost cleared skin.
Can smart home technology help chronic disease patients lead more comfortable lives?
Researchers at University of California have created and are testing artificial tissue, which appears to be up to six times as strong as natural cartilage.